Amedisys, Inc. AMED NASDAQ

Amedisys, Inc. (AMED) reported total assets of $2.14B and total liabilities of $958.75M for fiscal year 2024, resulting in total equity of $1.18B.

The company held $303.24M in cash and short-term investments. Total debt stood at $460.18M, with net debt of $156.94M. The Debt-to-Equity (D/E) ratio was 0.39 (conservative).

Current ratio is 1.23, suggesting adequate short-term liquidity. Interest coverage is 3.1x (adequate).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (63/100) — Total assets $2.14B and equity $1.18B support the company's competitive scale
• VALUE (57/100) — Debt-to-Equity 0.39 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 60/100 with 1/7 criteria passed.

UHS

Universal Health Services, Inc.

$181.95

-0.68%

ENSG

The Ensign Group, Inc.

$198.45

-0.92%

EHC

Encompass Health Corporation

$106.70

-0.80%

OPCH

Option Care Health, Inc.

$27.90

-3.56%

NHC

National HealthCare Corporation

$163.50

-3.60%

ACHC

Acadia Healthcare Company, Inc.

$26.56

+0.04%

ADUS

Addus HomeCare Corporation

$93.23

-1.96%

SGRY

Surgery Partners, Inc.

$13.10

+0.08%